Clinical trial
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma…
NCT00436696 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00436696 |
|---|---|
| Title | Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions |
| Official title | Genetic Basis of Neuroblastoma Tumorigenesis |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma |
| Intervention type | Other |
| Interventions | Laboratory Biomarker Analysis |
| Enrollment | 9,350 |
| Start date | Dec 11, 2006 |
| Primary completion | May 5, 2016 |
| First posted | Feb 19, 2007 |
| Last update posted | Aug 7, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: